CSL's Naylor to head flu vaccine unit

Typically the only new role of interest to a company’s chief financial officer would be the chief executive role, so it’s interesting to see CSL’s (ASX: CSL) CFO Gordon Naylor hanging up his calculator to head up the company’s new global influenza vaccine business.The business will be created by the merger of CSL’s existing vaccines subsidiary, bioCSL, with an influenza vaccine business which CSL has agreed to buy from Novartis (NYSE: NVS) for US$275m last October. The deal is still subject to regulatory approvals, but is expected to complete in December 2015.Naylor has been with CSL since 1987 and held...

Typically the only new role of interest to a company’s chief financial officer would be the chief executive role, so it’s interesting to see CSL’s (ASX: CSL) CFO Gordon Naylor hanging up his calculator to head up the company’s new global influenza vaccine business.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles